Invesco's Kristina Hooper believes Wall Street's preoccupation with the global growth slowdown is misguided.
But she understands why there's worry.
According to Hooper, significant shifts in central banks' monetary policies are fanning those fears instead of giving the market confidence. She suggests it's creating more questions than answers — and that's a problem.
"I don't think the slowdown is going to be that bad as we sit here today, and certainly that's not what we got from the ECB [European Central Bank] in terms of their downgrade of growth forecasts," the firm's chief global market strategist said Thursday on CNBC's "Futures Now." "We're not seeing any kind of major turmoil at this point."
The latest shift came last week when the ECB slashed its growth forecasts and issued a warning about the "threat of protectionism."
Top 5 Stocks To Invest In 2019: Novo Nordisk A/S(NVO)
Advisors' Opinion:- [By Stephan Byrd]
Atria Investments LLC trimmed its stake in Novo Nordisk (NYSE:NVO) by 17.4% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 7,081 shares of the company’s stock after selling 1,495 shares during the quarter. Atria Investments LLC’s holdings in Novo Nordisk were worth $349,000 as of its most recent SEC filing.
- [By Motley Fool Staff]
Anyway, what was also happening that day is that this list of five stocks came out. The theme was Five More Stocks to Feed the Next Bear. The reason it was called that is because, this is almost an ongoing five-stock samplers series. We'd first picked stocks in advance of a bear market in 2016. My talented producer Rick Engdahl decided we'd call this this Five More Stocks to Feed the Next Bear. Emily Flippen, these five companies came out. They were, we'll go with alphabetical order based on company name. They were Alphabet, Amazon, Apple (NASDAQ:AAPL), Novo Nordisk (NYSE:NVO), and Tencent.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Novo Nordisk A/S (NVO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Todd Campbell]
Its best-selling drug is the $2.9 billion-per-year, rapid-acting insulin, Humalog; its fastest-growing diabetes drug is Basaglar, a biosimilar to Sanofi's (NYSE:SNY) megablockbuster, long-lasting insulin, Lantus. In the past, Humalog has competed successfully for market share against Novo Nordisk's (NYSE:NVO) mealtime insulin, NovoLog; however, Humalog's patent has expired, and a new biosimilar, Admelog, from Sanofi became available earlier this year.
Top 5 Stocks To Invest In 2019: Zosano Pharma Corporation(ZSAN)
Advisors' Opinion:- [By Joseph Griffin]
Zosano Pharma (NASDAQ:ZSAN) will announce its earnings results after the market closes on Tuesday, May 15th.
Zosano Pharma (NASDAQ:ZSAN) last issued its quarterly earnings results on Monday, March 12th. The biotechnology company reported ($3.80) EPS for the quarter, topping analysts’ consensus estimates of ($4.80) by $1.00.
- [By Paul Ausick]
Zosano Pharma Corp. (NASDAQ: ZSAN) dropped about 17% Tuesday to post a new 52-week low of $0.54 after closing at $0.65 on Friday. Volume was around 720,000, about 10% below the daily average of around 850,000. The company had no specific news.
- [By Money Morning Staff Reports]
After looking at last week's top penny stocks, we'll show you this top penny stock…
Penny Stock Sector Current Share Price Last Week's Gain Sky Solar Holdings Ltd. (NASDAQ: SKYS) Utilities $1.19 111.74% Zosano Pharma Corp. (NASDAQ: ZSAN) Healthcare $4.54 106.36% Achieve Life Sciences Inc. (NASDAQ: ACHV) Healthcare $3.30 89.66% EnSync Inc. (NYSE: ESNC) Industrial Goods $0.13 85.00% Riot Blockchain Inc. (NASDAQ: RIOT) Healthcare $3.95 74.78% Ideanomics Inc. (NASDAQ: IDEX) Technologies $1.97 71.30% Eco-Stim Energy Solutions Inc. (OTCMKTS: ESES) Basic Materials $0.27 54.65% Pier 1 Imports Inc. (NYSE: PIR) Services $1.31 47.91% Marathon Patent Group Inc. (NASDAQ: MARA) Services $0.74 42.29% China Internet NationWide Financial Services Inc. (NASDAQ: CIFS) Financial $1.28 42.24%As you can see, knowing where to look for the top penny stocks could reward you with double-digit, or even triple-digit, returns in mere days.
Top 5 Stocks To Invest In 2019: RadiSys Corporation(RSYS)
Advisors' Opinion:- [By Joseph Griffin]
RadiSys (NASDAQ: RSYS) and Stratasys (NASDAQ:SSYS) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.
- [By Logan Wallace]
RadiSys (NASDAQ: RSYS) and Fortinet (NASDAQ:FTNT) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends.
- [By Alexander Bird]
Here are the top performers from last week…
Penny Stock Current Share Price Last Week's Gain Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71% Radisys Corp. (Nasdaq: RSYS) $1.55 115.68% Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12% Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63% Tintri Inc. (Nasdaq: TNTR) $0.18 40.49% Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96% Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40% Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40% ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65% SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.
- [By Shane Hupp]
Get a free copy of the Zacks research report on RadiSys (RSYS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Media stories about RadiSys (NASDAQ:RSYS) have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern scores the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. RadiSys earned a news impact score of 0.14 on Accern’s scale. Accern also gave media headlines about the technology company an impact score of 47.9028445830012 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Top 5 Stocks To Invest In 2019: LightPath Technologies, Inc.(LPTH)
Advisors' Opinion:- [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
- [By Joseph Griffin]
Headlines about LightPath Technologies (NASDAQ:LPTH) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LightPath Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 46.9867601112654 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Top 5 Stocks To Invest In 2019: CM Finance Inc(CMFN)
Advisors' Opinion:- [By Max Byerly]
ValuEngine upgraded shares of CM Finance (NASDAQ:CMFN) from a sell rating to a hold rating in a research note released on Thursday morning.
Several other analysts have also recently weighed in on CMFN. UBS cut shares of CM Finance from an outperform rating to a market perform rating in a research note on Friday, February 9th. Raymond James cut shares of CM Finance from an outperform rating to a market perform rating in a research note on Friday, February 9th. Redburn Partners cut shares of CM Finance from an outperform rating to a market perform rating in a research note on Friday, February 9th. Finally, Zacks Investment Research cut shares of CM Finance from a hold rating to a sell rating in a research note on Tuesday, April 10th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. CM Finance has a consensus rating of Hold and a consensus price target of $9.75.
- [By Shane Hupp]
Get a free copy of the Zacks research report on CM Finance (CMFN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
CM Finance (NASDAQ: CMFN) is one of 35 publicly-traded companies in the “Investors, not elsewhere classified” industry, but how does it weigh in compared to its peers? We will compare CM Finance to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, risk, institutional ownership and profitability.
- [By Stephan Byrd]
CM Finance Inc (NASDAQ:CMFN) – Analysts at Oppenheimer dropped their Q1 2019 earnings estimates for CM Finance in a report released on Wednesday, September 5th. Oppenheimer analyst C. Kotowski now anticipates that the investment management company will earn $0.25 per share for the quarter, down from their prior forecast of $0.27. Oppenheimer also issued estimates for CM Finance’s Q2 2019 earnings at $0.26 EPS, Q3 2019 earnings at $0.26 EPS, Q4 2019 earnings at $0.26 EPS and FY2019 earnings at $1.03 EPS.
No comments:
Post a Comment